Table 4

Sample sizes for each objective of the Adherence Guideline impact evaluation study in South Africa

ObjectiveSample sizeRationale
Objective 1—fast track ART initiation counselling720 patientsThe RapIT study of rapid ART initiation,16 conducted at a well-managed PHC in Gauteng Province, found that about 60% of ART-eligible patients initiated under standard care within 30 days. Conservatively assuming 60% initiation without the intervention and 75% with the intervention, 30 subjects in each of the 24 clusters for 720 total subjects will be required to detect a difference of 15%. We have increased this by 20% to account for ineligible patients.
Objective 2—adherence clubs576 patientsData from Themba Lethu Clinic17–19 show that about 80% of patients made all of their medication pickups over a 3-month period. It is anticipated that 24 subjects per clinic for a total of 576 patients will be needed to detect a difference of 15%. We have increased this by 20% to account for ineligible patients.
Objective 3—decentralised medication delivery576 patientsData from Themba Lethu Clinic17–19 show about 80% of patients made all of their medication pickups over a 3-month period. It is anticipated that 24 subjects per clinic for a total of 576 patients will be needed to detect a difference of 15%. We have increased this by 20% to account for ineligible patients.
Objective 4—enhanced adherence counselling1008 patientsData from KwaZulu-Natal Province indicate that 52% of patients with a detectable viral load resuppress after one session. It is anticipated that 42 subjects per clinic for a total of 1008 patients will be needed to detect a difference of 15%. We have increased this by 20% to account for ineligible patients.
Objective 5—early tracing of patients lost to follow-up576 patientsData from various Right to Care clinics19 suggest that the proportion of patients who are lost from care who return with no or little intervention is low, between 20% and 35%. It is anticipated that 24 subjects per clinic for a total of 576 patients will be needed to detect a difference of 15% assuming a baseline of 30% loss to follow-up without intervention. We have increased this by 20% to account for ineligible patients.
  • ART, antiretroviral therapy; PHC, primary healthcare clinic; RapIT, Rapid Initiation of Treatment Trial.